fashion -WSS

fashion

author：entertainment 2025-09-30 18:16:14 - browse：2

Colorful one hundred dollar bills -- health tech coverage from STAT — Adobe

Hospitals aren’t usually in the business of selling technology tools. But that’s changing thanks to a collision of financial pressures and an explosion of new technology that could both improve patients’ health and ease the burden of administrative tasks on limited staff.

At the J.P. Morgan Healthcare conference, an exclusive, invitation-only event for investors, several influential health systems like Mayo Clinic and Mass General Brigham doubled down on new revenue streams including advising companies building artificial intelligence tools or licensing out custom built products as they brace for a tough 2024.

Selling tech isn’t entirely new: a subset of hospitals and academic centers have been licensing out risk models and health record tools for decades. But now, a “perfect storm” of shrinking profit margins and philanthropic dollars, workforce shortages and rising labor costs is driving more hospitals to explore selling new technology they have built, like scheduling or clinical note summary tools, more than they have before, according to Dana Rollison, chief data officer at Moffitt Cancer Center.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Amylyx's ALS drug launch starts strong. It could be trouble for FDA

WSS

Naloxone nonprofit donates 200,000 doses after FDA approval

Naloxone nonprofit donates 200,000 doses after FDA approval

What we’ve learned from the Aduhelm mess

Drastic changes should bring profitability, startup health insurers say

Doctors' information doesn't help them choose wisely when sick

The dental labor crisis is a moment of opportunity

knowledge

fashion

focus

Sports medicine is finally prioritizing gender equality

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

State Dept. review finds Biden bears some blame for Afghanistan failures

Methadone doses haven’t kept up in the age of fentanyl

Peter Hotez and the public health issue of online harassment

For Medicare Advantage, Democrats want stronger protections around AI

Novavax promises a turnaround & Lilly roils the obesity market

PhRMA lawsuit over Medicare drug price negotiation tossed

Activists slam private health insurers over coverage restrictions

Biogen Alzheimer’s drug launch off to slow start

explore

What we’ve learned from the Aduhelm mess

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

To avoid data mishandling cases, universities eye AI and other tools

Maui's cultural, historic landmarks damaged in the devastating wildfires

A disappointing year of Humira biosimilars

Key House Republican on health care plans exit from Congress

focus

focus

focus

focus